SYNTHESIS, CHARACTERIZATION, MOLECULAR DOCKING, AND ANTICANCER ACTIVITY OF NEW FORMAZAN DERIVATIVES
Downloads
Objective: This work includes novel formazan compounds containing 5-diazenyl-2-hydroxybenzoic acid with different Schiff bases. SB1 ( N-(6-methoxybenzo[d]thiazol-2-yl)-1-(4-(pyridin-2-yl)phenyl)methanimine), SB2 ( dimethylene(4-((4-(pyridin-2-yl)benzylidene)amino)phenyl)-l6-sulfanamine), SB3 4-(((4-methoxy-6-methyl-1,3,5-triazin-2-yl)imino)methyl)-N,N-dimethylaniline) and SB4 ( 4-(((4-methoxy-6-methyl-1,3,5-triazin-2-yl)imino)methyl)benzene-1,3-diol) leads to formation F1 ( 2-hydroxy-5-((((6-methoxybenzo[d]thiazol-2-yl)imino)(4-(pyridin-2-yl)phenyl)methyl)diazenyl)benzoic acid), F2 ( 5-((((4-(aminodimethylene-l6-sulfaneyl)phenyl)imino)(4-(pyridin-2-yl)phenyl)methyl)diazenyl)-2-hydroxybenzoic acid), F3 (5-(((4-(dimethylamino)phenyl)((4-methoxy-6-methyl-1,3,5-triazin-2-yl)imino)methyl)diazenyl)-2-hydroxybenzoic acid) and F4 ( 5-(((2,4-dihydroxyphenyl)((4-methoxy-6-methyl-1,3,5-triazin-2-yl)imino)methyl)diazenyl)-2-hydroxybenzoic acid) in order. Method: They have been synthesized by the addition reaction of the diazonium salts of 5-diazenyl-2-hydroxybenzoic acid with Schiff bases, and they were designed, synthesized, and confirmed by elemental analyses, FT-IR, 1H-NMR and 13C-NMR spectral data. It noticed the molecular docking results for the interaction of the tested ligands (F1, F2, F3, F4) with the 1T49 protein (PTP1B) reveal several important insights regarding their binding affinities, stability of poses, and interaction profiles within the active site of the enzyme. Results: This suggests that F1 is the best candidate for further development as a potential PTP1B inhibitor, especially in relation to treatment for the breast cancer. All these results are consistent with what this work has reached when conducting an anti-cancer test. This work has investigated the cytotoxic potential of F1 against cell line MCF-7 (breast cancer). Results showed that the compound exhibited significant cytotoxicity toward MCF-7 cells, with an IC₅₀ of 147.6 µg/mL. These findings suggest a selective antiproliferative effect of the compound on cancerous cells compared to normal cells, highlighting its potential as a promising candidate for further anticancer drug development targeting breast cancer. Novelty: This work includes novel formazan compounds containing 5-diazenyl-2-hydroxybenzoic acid with different Schiff bases.
N. M. Aljamali, A. J. Kadhim, J. H. Mohammed, R. A. A. Ghafil, A. JK, and R. AAG, “Review on preparation and applications of formazan compounds,” Int. J. Thermodyn. Chem. Kinet., vol. 5, no. 2, pp. 23–33, 2019.
L. Hunter and C. B. Roberts, “145. The associating effect of the hydrogen atom. Part IX. The N–H–N bond. Virtual tautomerism of the formazyl compounds,” J. Chem. Soc. (Resumed), pp. 820–823, 1941.
A. M. Mattson, C. O. Jensen, and R. A. Dutcher, “The preparation of 2, 3, 5-triphenyltetrazolium chloride,” J. Am. Chem. Soc., vol. 70, no. 3, pp. 1284–1284, 1948.
J. W. Lewis and C. Sandorfy, “Infrared absorption and resonance Raman scattering of photochromic triphenylformazans,” Can. J. Chem., vol. 61, no. 5, pp. 809–816, 1983.
H. Tezcan, “The synthesis of some bis-substituted formazans and the investigation of the effect of substituent upon their UV-VIS absorption λmax values,” Commun. Fac. Sci. Univ. Ankara Ser. B Chem. Chem. Eng., vol. 51, no. 01, 2005.
H. Tezcan, “The synthesis of some bis-substituted formazans and the investigation of the effect of substituent upon their UV-VIS absorption λmax values,” Commun. Fac. Sci. Univ. Ankara Ser. B Chem. Chem. Eng., vol. 51, no. 01, 2005.
P. Friese, “Zur kenntniss der gemischten azoverbindungen,” Ber. Dtsch. Chem. Ges., vol. 8, no. 2, pp. 1078–1080, 1875.
P. B. Fischer, B. L. Kaul, and H. Zollinger, “Untersuchungen über die Struktur von Formazanen I. 15N‐H‐Kopplung des Chelatwasserstoffatoms,” Helv. Chim. Acta, vol. 51, no. 6, pp. 1449–1451, 1968.
Y. Gok and H. B. Senturk, “The synthesis and characterization of novel bis (formazans),” Org. Prep. Proced. Int., vol. 27, no. 1, pp. 87–91, 1995.
H. M. Luaibi, B. Alfarhani, and M. I. Kadhim, “Detection of Fe (III) levels via two different spectrophotometric methods in Diwaniah city/Iraq,” J. Eng. Appl. Sci., vol. 13, no. 24, pp. 10380–10383, 2018.
Y. H. Al-Araji, J. K. Shneine, and A. A. Ahmed, “Chemistry of formazan,” Int. J. Res. Pharm. Chem., vol. 5, no. 1, p. 36, 2015.
S. B. Chavan, S. B. Zangade, A. Y. Vibhute, and Y. B. Vibhute, “Synthesis and evaluation of antimicrobial activity of some new Schiff bases and formazans,” unpublished.
V. S. Misra, S. Dhar, and B. L. Chowdhary, “Synthesis of some newer formazans and tetrazolium salts as antiviral agents,” Pharmazie, vol. 33, no. 12, pp. 790–792, 1978.
R. Kalsi, K. Pande, T. N. Bhalla, S. S. Parmar, and J. P. Barthwal, “Novel formazans as potent anti-inflammatory and analgesic agents,” Pharmacology, vol. 37, no. 4, pp. 218–224, 1988.
J. M. Desai and V. H. Shah, “Synthesis and antimicrobial profile of 5-imidazolinones, sulphonamides, azomethines, 2-azetidinones and formazans derived from 2-amino-3-cyano-5-(5'-chloro-3'-methyl-1'-phenylpyrazol-4'-yl vinyl)-7, 7-dimethyl-6, 7-dihydrobenzo (b) thiophenes,” Indian J. Chem. Sect. B, vol. 42, no. 3, pp. 631–635, 2003.
K. G. Desai and K. R. Desai, “Microbial screening of novel synthesized formazans having amide linkages,” J. Heterocycl. Chem., vol. 43, no. 4, pp. 1083–1089, 2006.
J. A. Plumb, R. Milroy, and S. B. Kaye, “Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay,” Cancer Res., vol. 49, no. 16, pp. 4435–4440, 1989.
D. A. Scudiero et al., “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines,” Cancer Res., vol. 48, no. 17, pp. 4827–4833, 1988.
H. Wan, R. L. Williams, P. J. Doherty, and D. F. Williams, “The cytotoxicity evaluation of Kevlar and silicon carbide by MTT assay,” J. Mater. Sci. Mater. Med., vol. 5, no. 6, pp. 441–445, 1994.
S. A. O’Toole et al., “The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours,” Cancer Detect. Prev., vol. 27, no. 1, pp. 47–54, 2003.
D. M. Aziz, “Assessment of bovine sperm viability by MTT reduction assay,” Anim. Reprod. Sci., vol. 92, nos. 1–2, pp. 1–8, 2006.
S. D. Bhardwaj and V. S. Jolly, “Synthesis, anti-HIV and anticancer activities of some new formazans,” Asian J. Chem., vol. 9, no. 1, p. 48, 1997.
V. D. Saharan and S. S. Mahajan, “Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis,” Bioorg. Med. Chem. Lett., vol. 27, no. 4, pp. 808–815, 2017.
R. M. Desai and J. M. Desai, “Synthesis and antimicrobial activity of some new formazan derivatives,” Indian J. Heterocycl. Chem., vol. 8, no. 4, pp. 329–331, 1999.
O. S. Dahham et al., “Synthesis and structural studies of an epoxidized natural rubber/titania (ENR-50/TiO₂) hybrid under mild acid conditions,” Polym. Test., vol. 65, pp. 10–20, 2018.
O. S. Dahham et al., “NMR study of ring opening reaction of epoxidized natural rubber in presence of potassium hydroxide/isopropanol solution,” Polym. Test., vol. 59, pp. 55–66, 2017.
R. Hamzah, M. A. Bakar, O. S. Dahham, N. N. Zulkepli, and S. S. Dahham, “A structural study of epoxidized natural rubber (ENR‐50) ring opening under mild acidic condition,” J. Appl. Polym. Sci., vol. 133, no. 43, 2016.
O. S. Dahham et al., “Insight on the structural aspect of ENR-50/TiO₂ hybrid in KOH/C₃H₈O medium revealed by NMR spectroscopy,” Arab. J. Chem., vol. 13, no. 1, pp. 2400–2413, 2020.
M. F. Hassan and M. I. Kadhim, “Preparation, the spectroscopic and biological study of some derivatives of (β-lactam, oxazepine, and imidazole) linked to a heterocyclic nucleus,” in AIP Conf. Proc., Dec. 2023, vol. 2834, no. 1, p. 030006.
H. Tezcan, E. Uzluk, and M. L. Aksu, “Electrochemical and spectroscopic properties of 1:2 Ni complexes of 1,3-substitued (CH₃, OCH₃) phenyl-5-phenylformazans,” Electrochim. Acta, vol. 53, no. 18, pp. 5597–5607, 2008.
N. B. Arslan et al., “Direct and solvent-assisted thione–thiol tautomerism in 5-(thiophen-2-yl)-1,3,4-oxadiazole-2(3H)-thione: Experimental and molecular modeling study,” Chem. Phys., vol. 439, pp. 1–11, 2014.
Y. Sun, Y. Wang, Z. Liu, C. Huang, and C. Yu, “Structural, proton-transfer, thermodynamic and nonlinear optical studies of (E)-2-((2-hydroxyphenyl) iminiomethyl) phenolate,” Spectrochim. Acta A Mol. Biomol. Spectrosc., vol. 96, pp. 42–50, 2012.
H. Tavakol, “DFT and MP2 study of isomery scheme in formazan and intermolecular and intramolecular proton transfer between its tautomers,” Int. J. Quantum Chem., vol. 112, no. 4, pp. 1215–1224, 2012.
A. W. Nineham, “The chemistry of formazans and tetrazolium salts,” Chem. Rev., vol. 55, no. 2, pp. 355–483, 1955.
L. Hunter and C. B. Roberts, “145. The associating effect of the hydrogen atom. Part IX. The N–H–N bond. Virtual tautomerism of the formazyl compounds,” J. Chem. Soc. (Resumed), pp. 820–823, 1941.
N. J. Bagya and M. I. Kadhim, “Synthesis, characterization, and molecular docking of new heterocyclic compounds with evaluation of their biological activities,” Russ. J. Gen. Chem., vol. 95, no. 7, pp. 1–9, 2025, doi: 10.1134/S1070363225602479.
A. A. Muhee, “Synthesis and study of anticancer and antimicrobial activity of some new derivatives of thiazolidine, β-lactam, tetrazole, imidazolidine, oxazepine, formazan and quinazoline,” M.S. thesis, Univ. Al-Qadisiyah, College of Science, Al-Dewanya, Iraq, 2025.
G. Mariappan et al., “Synthesis and biological evaluation of formazan derivatives,” J. Adv. Pharm. Technol. Res., vol. 1, no. 4, pp. 396–400, 2010.
H. Tezcan, E. Uzluk, and M. L. Aksu, “Electrochemical and spectroscopic properties of 1:2 Ni complexes of 1,3-substitued (CH₃, OCH₃) phenyl-5-phenylformazans,” Electrochim. Acta, vol. 53, no. 18, pp. 5597–5607, 2008.
H. Moriwaki et al., “FMOe: Preprocessing and visualizing package of the fragment molecular orbital method for Molecular Operating Environment and its applications in covalent ligand and metalloprotein analyses,” J. Chem. Inf. Model., vol. 64, no. 18, pp. 6927–6937, 2024.
N. M. Aljamali and H. M. Azeez, “Synthesis and characterization of some new formazan-cefixime and study of against breast cancer cells,” Ann. Rom. Soc. Cell Biol., vol. 25, no. 3, pp. 8562–8578, 2021.
Copyright (c) 2025 Abdulsattar Hashim A. Ghani, Moayed Nemma Mohammed, Muqdad Irhaeem Kadhim
This work is licensed under a Creative Commons Attribution 4.0 International License.
